In addition to Michael Pierschbacher and Gregory Hook, the following individuals also serve on the Board of Directors of American Life Science Pharmaceuticals.
Steven Richieri, Chairman of the Board
Senior Vice President, Operations Photothera, Inc.
Steven Richieri is a Co-founder of American Life Science Pharmaceuticals and has been Senior Vice President, Operations of Photothera, Inc. since August 2006. Mr. Richieri has over 20 years of experience in the healthcare industry, and has a broad background in biotechnology, pharmaceutical and medical device companies and developing organizations and technology for commercial success. Mr. Richieri has held senior executive positions at Egea Biosciences, Inc. (a privately held company sold to the Johnson and Johnson Corporation), The Immune Response Corporation and Dura Pharmaceuticals and is a co-founder of NuVista Technology Corporation, a privately held medical device company.
Mr. Richieri holds a degree in Pharmacy from Rutgers College of Pharmacy and an M.B.A. from the University of San Diego.
J. Gregory Swendsen
President of Swendsen & Company
J. Gregory Swendsen is President of Swendsen & Company, a management company founded in 1984 that specializes in venture capital in the applied technologies. Mr. Swendsen is a founder of SuperGen, Inc. (NASDAQ: SUPG), a leading developer of anti-cancer drugs, a founder of Quark Biotech, and served on the board of AMUR Pharmaceuticals, which he financed prior to its sale to SuperGen. Mr. Swendsen has raised over $250 million for pharmaceutical and biotech companies. He currently sits on the board of Planet Biotech, and KineMed, Inc.
< Back
